Cargando…

Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures

SIMPLE SUMMARY: Patients with Triple Negative Breast Cancer (TNBC) have a poor prognosis due to high inter-tumor heterogeneity and absence of effective targeted treatments. Through quantification of ongoing processes in each individual with TNBC, we propose an explanation on why certain previously s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasudevan, Swetha, Adejumobi, Ibukun A., Alkhatib, Heba, Roy Chowdhury, Sangita, Stefansky, Shira, Rubinstein, Ariel M., Kravchenko-Balasha, Nataly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507629/ https://www.ncbi.nlm.nih.gov/pubmed/34638492 http://dx.doi.org/10.3390/cancers13195009

Ejemplares similares

Overcoming resistance to BRAF(V600E) inhibition in melanoma by deciphering and targeting personalized protein network alterations
por: Vasudevan, S., et al.
Publicado: (2021)

Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy
por: Flashner-Abramson, Efrat, et al.
Publicado: (2019)

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
por: Alkhatib, Heba, et al.
Publicado: (2022)

Exploring Alzheimer’s Disease Molecular Variability via Calculation of Personalized Transcriptional Signatures
por: Dagan, Hila, et al.
Publicado: (2020)

Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading
por: Jubran, Maria R., et al.
Publicado: (2020)

Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
por: Jubran, Maria R., et al.
Publicado: (2022)

Overexpressed kinetochore genes are used by cancer cells as genome destabilizers and transformation catalysts
por: Aldwaik, Reem Kamal, et al.
Publicado: (2023)

Explant Modeling of the Immune Environment of Head and Neck Cancer
por: Sharon, Shay, et al.
Publicado: (2021)

Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means
por: Cohen, Noam, et al.
Publicado: (2013)

Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
por: Rabah, Nadin, et al.
Publicado: (2023)

Anomalous Features of EMT during Keratinocyte Transformation
por: Geiger, Tamar, et al.
Publicado: (2008)

Computational Surprisal Analysis Speeds-Up Genomic Characterization of Cancer Processes
por: Kravchenko-Balasha, Nataly, et al.
Publicado: (2014)

Optimization of Energy-Consuming Pathways towards Rapid Growth in HPV-Transformed Cells
por: Mizrachy-Schwartz, Sarit, et al.
Publicado: (2007)

Convergence of Logic of Cellular Regulation in Different Premalignant Cells by an Information Theoretic Approach
por: Kravchenko-Balasha, Nataly, et al.
Publicado: (2011)

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
por: Sharon, Shay, et al.
Publicado: (2023)

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
por: Zahavi, Tamar, et al.
Publicado: (2021)

Paclitaxel Delivery to the Brain for Glioblastoma Treatment
por: AbdEl-haq, Muhammad, et al.
Publicado: (2023)

MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature
por: Adriá-Cebrián, Jose, et al.
Publicado: (2021)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Morphine-induced hallucinations - resolution with switching to oxycodone: a case report and review of the literature
por: Chowdhury, Mursheda Mahbub, et al.
Publicado: (2009)

Distinct microbiological signatures associated with triple negative breast cancer
por: Banerjee, Sagarika, et al.
Publicado: (2015)

HU308 Mitigates Osteoarthritis by Stimulating Sox9‐Related Networks of Carbohydrate Metabolism
por: Carmon, Idan, et al.
Publicado: (2022)

Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2023)

miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
por: Nassirpour, Rounak, et al.
Publicado: (2013)

Clinical Characteristics in Patients with Triple Negative Breast Cancer
por: Yeh, Janet, et al.
Publicado: (2017)

Switching Off Key Signaling Survival Molecules to Switch On the Resolution of Inflammation
por: Perez, Denise Alves, et al.
Publicado: (2014)

Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
por: Echeverria, Gloria V., et al.
Publicado: (2018)

Novel therapeutic strategies in the treatment of triple-negative breast cancer
por: Oualla, Karima, et al.
Publicado: (2017)

Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021)

Nanometer resolution imaging by single molecule switching
por: Hu, Dehong, et al.
Publicado: (2010)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

Three-microRNA expression signature predicts survival in triple-negative breast cancer
por: Wu, Xinquan, et al.
Publicado: (2020)

Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature
por: Pralea, Ioana-Ecaterina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ma84334epr8papvj5p76tihthi